Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Hepatitis BLiver Cirrhosis
Interventions
DRUG

Entecavir

oral entecavir 0.5mg daily for 8 years

Trial Locations (20)

30001

The First Hospital of Shanxi Medical University, Taiyuan

50021

Shijiazhuang Fifth Hospital, Shijiazhuang

100034

Peking University First Hospital, Beijing

100039

302 Military Hospital Of China, Beijing

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

Beijing Tiantan Hospital, Capital Medical University, Beijing

Peking University People's Hospital, Beijing

100069

Beijing YouAn Hospital, Capital Medical University, Beijing

133000

The Affiliated Hospital of Yanbian University, Yanji

200032

Renji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai

200040

Zhongshan Hospital Fudan University, Shanghai

200080

Shanghai General Hospital, Shanghai

201508

Shanghai Public Health Clinical Center, Shanghai

300170

Tianjin Third Central Hospital, Tianjin

300380

Tianjin Xiqing Hospital, Tianjin

310016

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou

430030

Tongji Hospital, Tongji Medical College , Huazhong University of Science and Technology, Wuhan

510515

NanfangHospital,Southern Medical University, Guangzhou

710032

Xijing Hospital, Fourth Military Medical University, Xi’an

050051

The Third Hospital of Hebei Medical University, Shijiazhuang

All Listed Sponsors
collaborator

Peking University People's Hospital

OTHER

collaborator

Fudan University

OTHER

collaborator

Affiliated Hospital of Yanbian University

UNKNOWN

collaborator

Shanghai Public Health Clinical Center

OTHER_GOV

collaborator

Beijing YouAn Hospital

OTHER

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

lead

Beijing Friendship Hospital

OTHER